[BRIEFING.COM] The stock market exhibited some turbulence at the index level amid mixed headlines and corporate news. The S&P 500 (+0.1%) and the Nasdaq Composite (-0.1%) traded above and below prior closing levels while the Dow Jones Industrial Average (-1.3%) lagged its peers.
The underperformance of the DJIA was due to a significant earnings-related loss in UnitedHealth (UNH 454.11, -130.93, -22.4%), which is among the heaviest components in the price-weighted average.
The overall bias in the market was positive, however. The equal-weighted S&P 500 closed 0.7% higher, the Russell 2000 registered a 0.9% gain, and the S&P Mid Cap 400 was up 0.8%. Also, market breadth was positive through the entire session. Advancing issues led declining issues by a 3-to-1 ratio at the NYSE and by a 2-to-1 margin at the Nasdaq.
Outsized moves were mostly reserved for individual stocks with specific catalysts. Eli Lilly (LLY 839.96, +105.06, +14.3%) was an influential winner after announcing positive trial results for its weight-loss drug pill.
Alphabet (GOOG 153.36, -2.14, -1.4%) was another influential mover, dropping after a Reuters report indicating a federal judge ruled that it holds an illegal monopoly in online advertising technology.
Treasuries settled with losses. The 10-yr yield was up five basis points today, and down 16 basis points this week, to 4.33%.
Reviewing today's economic data:
Looking ahead to Monday, market participants receive the following data: